Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Net Margin: 2019-2023

Historic Net Margin for ADC Therapeutics (ADCT) over the last 4 years, with Sep 2023 value amounting to -312.58%.

  • ADC Therapeutics' Net Margin fell 37889.00% to -312.58% in Q3 2023 from the same period last year, while for Sep 2023 it was -290.47%, marking a year-over-year decrease of 38439.00%. This contributed to the annual value of -74.22% for FY2022, which is 60398.00% up from last year.
  • ADC Therapeutics' Net Margin amounted to -312.58% in Q3 2023, which was down 25.05% from -249.96% recorded in Q2 2023.
  • Over the past 5 years, ADC Therapeutics' Net Margin peaked at 65,500.56% during Q1 2020, and registered a low of -993.00% during Q1 2021.
  • For the 3-year period, ADC Therapeutics' Net Margin averaged around 76.43%, with its median value being -34.61% (2022).
  • Per our database at Business Quant, ADC Therapeutics' Net Margin soared by 6,293,498bps in 2020 and then tumbled by 6,649,357bps in 2021.
  • Quarterly analysis of 5 years shows ADC Therapeutics' Net Margin stood at 0.00% in 2019, then surged by 6,293,498bps to 62,934.98% in 2020, then crashed by 6,239,076bps to -202.12% in 2021, then spiked by 16,751bps to -34.61% in 2022, then slumped by 37,889bps to -312.58% in 2023.
  • Its Net Margin stands at -312.58% for Q3 2023, versus -249.96% for Q2 2023 and -315.66% for Q1 2023.